We are live on ! Find out more
ACUR

Acura Pharmaceuticals
ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

Back to rankings

1 hedge funds and large institutions have $1.1M invested in Acura Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less capital invested

Capital invested by funds: $1.18M → $1.1M (-$81K)

67% less funds holding

Funds holding: 3 → 1 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$1.1M – – –

ACUR Hedge Fund Activity: Q2 2017 in Review

1 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q2 2017, worth a combined $1.1M — down 6.9% from $1.18M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ACUR and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

  • 1 institutional investor held Acura Pharmaceuticals (ACUR) as of Q2 2017, down from 3 in Q1 2017.
  • Funds reported $1.1M of Acura Pharmaceuticals stock for Q2 2017, down 6.9% quarter-over-quarter.
  • 0 funds opened new Acura Pharmaceuticals positions in Q2 2017 and 2 closed out, a net change of -2 holders.

Based on aggregated 13F filings for Q2 2017.